Royal Bank of Canada Downgrades Aveanna Healthcare (NASDAQ:AVAH) to Sector Perform

Royal Bank of Canada cut shares of Aveanna Healthcare (NASDAQ:AVAHGet Rating) from an outperform rating to a sector perform rating in a report released on Monday morning, Marketbeat reports. Royal Bank of Canada currently has $3.00 target price on the stock, down from their previous target price of $7.00.

Other equities research analysts also recently issued reports about the company. Credit Suisse Group downgraded Aveanna Healthcare from an outperform rating to a neutral rating and lowered their target price for the stock from $5.50 to $2.00 in a report on Thursday, November 17th. Barclays decreased their price objective on Aveanna Healthcare from $7.00 to $5.00 and set an overweight rating for the company in a report on Friday, August 19th. Truist Financial decreased their price objective on Aveanna Healthcare to $1.25 in a report on Wednesday, November 16th. Stephens decreased their price objective on Aveanna Healthcare from $2.25 to $1.50 and set an equal weight rating for the company in a report on Friday, November 11th. Finally, Raymond James cut their target price on Aveanna Healthcare from $8.00 to $6.00 and set a strong-buy rating on the stock in a research report on Monday, August 15th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating, two have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, Aveanna Healthcare has an average rating of Hold and an average target price of $3.25.

Aveanna Healthcare Stock Performance

AVAH opened at $0.74 on Monday. The firm has a market cap of $136.65 million, a P/E ratio of -0.25 and a beta of 0.91. Aveanna Healthcare has a 52-week low of $0.70 and a 52-week high of $7.71. The company has a debt-to-equity ratio of 5.63, a quick ratio of 0.89 and a current ratio of 0.89. The business’s fifty day moving average is $1.35 and its 200-day moving average is $2.03.

Aveanna Healthcare (NASDAQ:AVAHGet Rating) last released its quarterly earnings data on Wednesday, November 9th. The company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of $0.04 by ($0.07). Aveanna Healthcare had a negative net margin of 31.44% and a positive return on equity of 6.05%. The business had revenue of $443.01 million during the quarter, compared to analyst estimates of $448.84 million. Sell-side analysts expect that Aveanna Healthcare will post 0.08 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. SG Americas Securities LLC purchased a new position in Aveanna Healthcare in the second quarter worth $38,000. Victory Capital Management Inc. bought a new stake in shares of Aveanna Healthcare in the first quarter valued at $176,000. Natixis Investment Managers International bought a new stake in shares of Aveanna Healthcare in the second quarter valued at $357,000. Cornercap Investment Counsel Inc. raised its stake in shares of Aveanna Healthcare by 27.0% in the first quarter. Cornercap Investment Counsel Inc. now owns 199,563 shares of the company’s stock valued at $681,000 after buying an additional 42,461 shares during the period. Finally, Trilantic Capital Management L.P. raised its stake in shares of Aveanna Healthcare by 22.0% in the first quarter. Trilantic Capital Management L.P. now owns 664,986 shares of the company’s stock valued at $2,268,000 after buying an additional 120,000 shares during the period. Hedge funds and other institutional investors own 92.00% of the company’s stock.

Aveanna Healthcare Company Profile

(Get Rating)

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals.

Recommended Stories

Analyst Recommendations for Aveanna Healthcare (NASDAQ:AVAH)

Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.